Proteoglycans, glycosaminoglycans and amyloid deposition. 1994

J H Magnus, and T Stenstad, and G Husby
Department of Rheumatology, University Hospital, Tromsø, Norway.

UI MeSH Term Description Entries
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D004194 Disease A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. Diseases
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

J H Magnus, and T Stenstad, and G Husby
December 1992, Journal of internal medicine,
J H Magnus, and T Stenstad, and G Husby
January 1993, Comptes rendus des seances de la Societe de biologie et de ses filiales,
J H Magnus, and T Stenstad, and G Husby
February 2018, Pharmaceuticals (Basel, Switzerland),
J H Magnus, and T Stenstad, and G Husby
August 1999, Nihon rinsho. Japanese journal of clinical medicine,
J H Magnus, and T Stenstad, and G Husby
March 1995, Histopathology,
J H Magnus, and T Stenstad, and G Husby
January 1994, EXS,
J H Magnus, and T Stenstad, and G Husby
January 1972, Archiv fur dermatologische Forschung,
J H Magnus, and T Stenstad, and G Husby
December 2000, Scandinavian journal of immunology,
J H Magnus, and T Stenstad, and G Husby
April 2004, Orvosi hetilap,
J H Magnus, and T Stenstad, and G Husby
January 1998, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!